Digital Health in Pharma Insights
Boehringer Ingelheim
Applying AI in patient safety use cases
What’s the best way to introduce AI to enhance automation of high-volume pharmacovigilance activities, such as adverse event case intake and processing?
5 Nov 2025
bsd studio Shutterstock
Business transformation must precede AI implementation in pharmacovigilance
Updesh Dosanjh, practice leader, PV Technology Solutions, IQVIA explores the lesson: digital transformation in pharmacovigilance (PV) must be preceded by foundational business transformation.
26 Sep 2025
tadamichi Shutterstock
Agentic AI’s role in life science manufacturing
David Staunton, industry transformation leader at Cognizant Life Science Manufacturing shares how life sciences companies are under immense pressure to deliver new treatments to a global population faster.
25 Jul 2025
DeSci Labs
Why the process of selecting a pharma peer reviewer needs an AI upgrade
Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that peer review needs urgent reform and that AI can help pharma live up to its ideals.
22 Jul 2025
Who is Danny Shutterstock
Digitalisation of Pharma in 2025: what’s holding firms back?
Martyn Williams, managing director of COPA-DATA UK discusses digitalisation of pharma and what's holding firms back.
4 Jul 2025
Capula
Harnessing intelligent digital operations for efficiency
Neil White, head of digital sales from Capula discusses a practical approach to digitalisation in the pharmaceutical industry.
23 May 2025
Shutterstock Summit Art Creations
ACD/Labs announces Katalyst D2D software release
ACD/Labs, an informatics company that develops and commercialises software in support of digitalised R&D, has announced a new release of Katalyst D2D, the software for workflow digitalisation and data management in chemical and process development.
29 Oct 2025
Shutterstock anan sukprakon
Fundamental XR launches AI-powered anatomy inference engine
Fundamental XR has announced the launch of its Anatomy Inference Engine (AIE) BETA, an AI-powered platform that can generate realistic simulation ready 3D anatomical models in minutes rather than weeks.
17 Oct 2025
Shutterstock Sean Pavone
SPT Labtech and Agilent introduces automated target enrichment protocols
SPT Labtech and Agilent has announced the introduction of automated target enrichment protocols on SPT Labtech’s firefly+ platform.
9 Oct 2025
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Holistic IP strategy is needed for ‘off-the-shelf’ CAR T cell therapies
With so much investor interest surrounding the potential of allogeneic CAR T cell therapies, the stakes are high for innovators to ensure that their inventions are robustly protected from the start.
6 Nov 2025
Boehringer Ingelheim
Applying AI in patient safety use cases
What’s the best way to introduce AI to enhance automation of high-volume pharmacovigilance activities, such as adverse event case intake and processing?
5 Nov 2025
Tjoapack
Driving the revolution in packaging
Geert Vleugels, general manager at Tjoapack discusses the revolution in packaging.
4 Nov 2025
Olivia Friett
Were CPHI Frankfurt 2025 expectations met?
European Pharmaceutical Manufacturer asked various leaders in pharma what the highlights of CPHI 2025 were and if the event met expectations.
3 Nov 2025
BMG
Navigating complex regulatory landscapes
Rachel Houghton, managing director at Business Moves Group (BMG), explores how pharmaceutical manufacturers can navigate complex regulatory landscapes and safeguard sensitive equipment to ensure seamless international workplace transitions.
30 Oct 2025
Sirio Pharma
Using pharma-grade quality control in nutraceuticals
Kayla Pham, vice president of quality at Best Formulations/Sirio Pharma shares why more and more, nutrition and nutraceuticals brand owners are placing pharma-grade quality control atop their manufacturing partnership wish lists.
30 Oct 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00